Conexiant’s news site is now MDSpire News. Learn more
Advertisement
2026 ASCO Breast Cancer Highlights: SENOMAC
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss SENOMAC trial highlights related to whether some patients with early breast cancer and limited lymph node involvement can avoid additional axillary surgery.
Interpretation:
The supplied context identifies the speakers and topic but provides no trial results.
Limitations:
The supplied context does not include trial findings.
Breast cancer management is becoming increasingly biology-driven, with treatment decisions extending well beyond anatomic stage and conventional receptor classification.
